(S)-3-(2'-Amino-2-morpholino-4'-(trifluoromethyl)-[4,5'-bipyrimidin]-6-yl)-4-(hydroxymethyl)oxazolidin-2-one

ID: ALA5181013

Chembl Id: CHEMBL5181013

PubChem CID: 168276351

Max Phase: Preclinical

Molecular Formula: C17H18F3N7O4

Molecular Weight: 441.37

Names and Identifiers

Canonical SMILES:  Nc1ncc(-c2cc(N3CCOCC3)nc(N3C(=O)OC[C@@H]3CO)n2)c(C(F)(F)F)n1

Standard InChI:  InChI=1S/C17H18F3N7O4/c18-17(19,20)13-10(6-22-14(21)25-13)11-5-12(26-1-3-30-4-2-26)24-15(23-11)27-9(7-28)8-31-16(27)29/h5-6,9,28H,1-4,7-8H2,(H2,21,22,25)/t9-/m0/s1

Standard InChI Key:  OWBMLJHHHONAMV-VIFPVBQESA-N

Alternative Forms

1. Parent:

   

   ALA5181013

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 441.37

Molecular Weight (Monoisotopic): 441.1372

AlogP: 0.69

#Rotatable Bonds: 4

Polar Surface Area: 139.82

Molecular Species: NEUTRAL

HBA: 10

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 11

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 1

CX Acidic pKa: ┄

CX Basic pKa: 3.13

CX LogP: 1.35

CX LogD: 1.35

Aromatic Rings: 2

Heavy Atoms: 31

QED Weighted: 0.70

Np Likeness Score: -1.19

References

1. Fairhurst RA, Furet P, Imbach-Weese P, Stauffer F, Rueeger H, McCarthy C, Ripoche S, Oswald S, Arnaud B, Jary A, Maira M, Schnell C, Guthy DA, Wartmann M, Kiffe M, Desrayaud S, Blasco F, Widmer T, Seiler F, Gutmann S, Knapp M, Caravatti G..  (2022)  Identification of NVP-CLR457 as an Orally Bioavailable Non-CNS-Penetrant pan-Class IA Phosphoinositol-3-Kinase Inhibitor.,  65  (12.0): [PMID:35500094] [10.1021/acs.jmedchem.2c00267]

Source

Source(1):

• Scientific Literature